DOI QR코드

DOI QR Code

Ginsenoside Rp1 Exerts Anti-inflammatory Effects via Activation of Dendritic Cells and Regulatory T Cells

  • Bae, Jin-Gyu (Department of Bioinformatics and Life Science, College of Natural Sciences, Soongsil University) ;
  • Koo, Ji-Hye (Department of Bioinformatics and Life Science, College of Natural Sciences, Soongsil University) ;
  • Kim, Soo-Chan (Department of Bioinformatics and Life Science, College of Natural Sciences, Soongsil University) ;
  • Park, Tae-Yoon (Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University) ;
  • Kim, Mi-Yeon (Department of Bioinformatics and Life Science, College of Natural Sciences, Soongsil University)
  • Received : 2012.05.18
  • Accepted : 2012.06.16
  • Published : 2012.10.15

Abstract

Ginsenoside Rp1 (G-Rp1) is a saponin derivate that provides anti-metastatic activities through inhibition of the NF-${\kappa}B$ pathway. In this study, we examined the effects of G-Rp1 on regulatory T cell (Treg) activation. After treatment of splenocytes with G-Rp1, Tregs exhibited upregulation of IL-10 expression, and along with dendritic cells (DCs), these Tregs showed increased cell number compared to other cell populations. The effect of G-Rp1 on Treg number was augmented in the presence of lipopolysaccharide (LPS), which mimics pathological changes that occur during inflammation. However, depletion of DCs prevented the increase in Treg number in the presence of G-Rp1 and/or LPS. In addition, G-Rp1 promoted the differentiation of the memory types of $CD4^+Foxp3^+CD62L^{low}$ Tregs rather than the generation of new Tregs. In vivo experiments also demonstrated that Tregs and DCs from mice that were fed G-Rp1 for 7 d and then injected with LPS exhibited increased activation compared with those from mice that were injected with LPS alone. Expression of TGF-${\beta}$ and CTLA4 in Tregs was increased, and upregulation of IL-2 and CD80/CD86 expression by DCs affected the suppressive function of Tregs through IL-2 receptors and CTLA4. These data demonstrate that G-Rp1 exerts anti-inflammatory effects by activating Tregs in vitro and in vivo.

Keywords

References

  1. Wang W, Zhao Y, Rayburn ER, Hill DL, Wang H, Zhang R. In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng. Cancer Chemother Pharmacol 2007;59:589-601. https://doi.org/10.1007/s00280-006-0300-z
  2. Tode T, Kikuchi Y, Kita T, Hirata J, Imaizumi E, Nagata I. Inhibitory effects by oral administration of ginsenoside Rh2 on the growth of human ovarian cancer cells in nude mice. J Cancer Res Clin Oncol 1993;120:24-26. https://doi.org/10.1007/BF01200720
  3. Kim HS, Lee EH, Ko SR, Choi KJ, Park JH, Im DS. Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells. Arch Pharm Res 2004;27:429-435. https://doi.org/10.1007/BF02980085
  4. Oh M, Choi YH, Choi S, Chung H, Kim K, Kim SI, Kim DK, Kim ND. Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells. Int J Oncol 1999;14:869-875.
  5. Shin JY, Lee JM, Shin HS, Park SY, Yang JE, Cho SK, Yi TH. Anti-cancer effect of ginsenoside F2 against glioblastoma multiforme in xenograft model in SD rats. J Ginseng Res 2012;36:86-92. https://doi.org/10.5142/jgr.2012.36.1.86
  6. Park MH, Park TY, inventor. Treatment and prevention of cancer with new ginsenoside derivatives. PCT/KR2005/001006. 2005 Jul 4.
  7. Kumar A, Kumar M, Panwar M, Samarth RM, Park TY, Park MH, Kimura H. Evaluation of chemopreventive action of ginsenoside Rp1. Biofactors 2006;26:29-43. https://doi.org/10.1002/biof.5520260104
  8. Park TY, Park MH, Shin WC, Rhee MH, Seo DW, Cho JY, Kim HM. Anti-metastatic potential of ginsenoside Rp1, a novel ginsenoside derivative. Biol Pharm Bull 2008;31:1802-1805. https://doi.org/10.1248/bpb.31.1802
  9. Kim BH, Lee YG, Park TY, Kim HB, Rhee MH, Cho JY. Ginsenoside Rp1, a ginsenoside derivative, blocks lipopolysaccharide-induced interleukin-1beta production via suppression of the NF-kappaB pathway. Planta Med 2009;75:321-326. https://doi.org/10.1055/s-0028-1112218
  10. Shen T, Lee JH, Park MH, Lee YG, Rho HS, Kwak YS, Rhee MH, Park YC, Cho JY. Ginsenoside Rp1, a ginsenoside derivative, blocks promoter activation of iNOS and COX-2 genes by suppression of an IKKbmediated NF-kB pathway in HEK293 cells. J Ginseng Res 2011;35:200-208. https://doi.org/10.5142/jgr.2011.35.2.200
  11. Bettelli E, Das MP, Howard ED, Weiner HL, Sobel RA, Kuchroo VK. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-defi cient and transgenic mice. J Immunol 1998;161:3299-3306.
  12. Bettelli E, Nicholson LB, Kuchroo VK. IL-10, a key effector regulatory cytokine in experimental autoimmune encephalomyelitis. J Autoimmun 2003;20:265-267. https://doi.org/10.1016/S0896-8411(03)00048-9
  13. Zheng Y, Rudensky AY. Foxp3 in control of the regulatory T cell lineage. Nat Immunol 2007;8:457-462. https://doi.org/10.1038/ni1455
  14. Feuerer M, Hill JA, Mathis D, Benoist C. Foxp3+ regulatory T cells: differentiation, specifi cation, subphenotypes. Nat Immunol 2009;10:689-695. https://doi.org/10.1038/ni.1760
  15. Rubtsov YP, Rasmussen JP, Chi EY, Fontenot J, Castelli L, Ye X, Treuting P, Siewe L, Roers A, Henderson WR Jr et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 2008;28:546-558. https://doi.org/10.1016/j.immuni.2008.02.017
  16. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-252. https://doi.org/10.1038/32588
  17. Cella M, Sallusto F, Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 1997;9:10-16. https://doi.org/10.1016/S0952-7915(97)80153-7
  18. Darrasse-Jeze G, Deroubaix S, Mouquet H, Victora GD, Eisenreich T, Yao KH, Masilamani RF, Dustin ML, Rudensky A, Liu K et al. Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J Exp Med 2009;206:1853-1862. https://doi.org/10.1084/jem.20090746
  19. Siepmann K, Biester S, Plskova J, Muckersie E, Duncan L, Forrester JV. CD4+ CD25+ T regulatory cells induced by LPS-activated bone marrow dendritic cells suppress experimental autoimmune uveoretinitis in vivo. Graefes Arch Clin Exp Ophthalmol 2007;245:221-229. https://doi.org/10.1007/s00417-006-0356-9
  20. Kim MY, Anderson G, White A, Jenkinson E, Arlt W, Martensson IL, Erlandsson L, Lane PJ. OX40 ligand and CD30 ligand are expressed on adult but not neonatal CD4+CD3- inducer cells: evidence that IL-7 signals regulate CD30 ligand but not OX40 ligand expression. J Immunol 2005;174:6686-6691. https://doi.org/10.4049/jimmunol.174.11.6686
  21. Kim S, Han S, Kim MY. Effects of interleukin-15 on human $CD3^-$ $CD117^+$ $CD56^-$ $OX40L^+$ cell differentiation. Hum Immunol 2010;71:745-750. https://doi.org/10.1016/j.humimm.2010.05.015
  22. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 2005;6:1219-1227. https://doi.org/10.1038/ni1265
  23. Kim S, Shim S, Choi DS, Kim JH, Kwon YB, Kwon J. Modulation of LPS-stimulated astroglial activation by ginseng total saponins. J Ginseng Res 2011;35:80-85. https://doi.org/10.5142/jgr.2011.35.1.080
  24. Van der Merwe PA, Bodian DL, Daenke S, Linsley P, Davis SJ. CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics. J Exp Med 1997;185:393-403. https://doi.org/10.1084/jem.185.3.393

Cited by

  1. Red Ginseng Extract Ameliorates Autoimmune Arthritis via Regulation of STAT3 Pathway, Th17/Treg Balance, and Osteoclastogenesis in Mice and Human vol.2014, pp.1466-1861, 2014, https://doi.org/10.1155/2014/351856
  2. Recent advances in ginseng as cancer therapeutics: a functional and mechanistic overview vol.32, pp.2, 2015, https://doi.org/10.1039/C4NP00080C
  3. Effects of ginsenosides on regulatory T cell differentiation pp.2092-6456, 2017, https://doi.org/10.1007/s10068-017-0255-3
  4. Chinese Herbal Medicine for Myasthenia Gravis: A Systematic Review and Meta-Analysis vol.9, pp.1663-9812, 2018, https://doi.org/10.3389/fphar.2018.00969
  5. Protective effects of red ginseng extract against vaginal herpes simplex virus infection vol.37, pp.2, 2012, https://doi.org/10.5142/jgr.2013.37.210
  6. Ginsenoside compound K suppresses the abnormal activation of T lymphocytes in mice with collagen-induced arthritis vol.35, pp.5, 2014, https://doi.org/10.1038/aps.2014.7
  7. Pro-Resolving Effect of Ginsenosides as an Anti-Inflammatory Mechanism of Panax ginseng vol.10, pp.3, 2020, https://doi.org/10.3390/biom10030444